Evaluation of Executive Functions in Children With Cochleovestibular Deficit
NCT ID: NCT05665907
Last Updated: 2022-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2023-01-01
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
children with vestibular dysfunction with hearing loss
children with vestibular dysfunction with hearing loss
Questionnaire BRIEF (Behavioral Rating Inventory of Executive Function)
Questionnaire BRIEF (Behavioral Rating Inventory of Executive Function)
children with vestibular dysfunction with normal inner ear function
children with vestibular dysfunction with normal inner ear function
Questionnaire BRIEF (Behavioral Rating Inventory of Executive Function)
Questionnaire BRIEF (Behavioral Rating Inventory of Executive Function)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire BRIEF (Behavioral Rating Inventory of Executive Function)
Questionnaire BRIEF (Behavioral Rating Inventory of Executive Function)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliated to the social security system
* Holders of parental authority and Patients informed and not opposed to participating in the research
* Mastery of the French language by patients and their parents
Exclusion Criteria
* Existence of another neurodevelopmental pathology or specific cognitive disorder
5 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Audrey MAUDOUX, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Robert Debre Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Audrey MAUDOUX, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDRCB: 2022-A00160-43
Identifier Type: REGISTRY
Identifier Source: secondary_id
APHP220224
Identifier Type: -
Identifier Source: org_study_id